ExodusPoint Capital Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Sell |
39,259
-1,668
| -4% | -$6.46K | ﹤0.01% | 1267 |
|
|
2025
Q1 | $205K | Buy |
+40,927
| New | +$205K | ﹤0.01% | 1234 |
|
|
2024
Q4 | – | Sell |
-45,769
| Closed | -$281K | – | 1348 |
|
|
2024
Q3 | $281K | Buy |
45,769
+28,259
| +161% | +$173K | ﹤0.01% | 1278 |
|
|
2024
Q2 | $116K | Sell |
17,510
-63,403
| -78% | -$420K | ﹤0.01% | 1286 |
|
|
2024
Q1 | $824K | Buy |
+80,913
| New | +$824K | 0.01% | 893 |
|
|
2022
Q3 | – | Sell |
-305,879
| Closed | -$3.58M | – | 1811 |
|
|
2022
Q2 | $3.58M | Buy |
305,879
+279,528
| +1,061% | +$3.27M | 0.04% | 497 |
|
|
2022
Q1 | $160K | Buy |
+26,351
| New | +$160K | ﹤0.01% | 1887 |
|
|
2021
Q4 | – | Sell |
-74,358
| Closed | -$841K | – | 2083 |
|
|
2021
Q3 | $841K | Buy |
74,358
+62,717
| +539% | +$709K | 0.01% | 1064 |
|
|
2021
Q2 | $115K | Sell |
11,641
-65,007
| -85% | -$642K | ﹤0.01% | 2046 |
|
|
2021
Q1 | $1.08M | Buy |
76,648
+59,435
| +345% | +$840K | 0.02% | 829 |
|
|
2020
Q4 | $194K | Buy |
+17,213
| New | +$194K | ﹤0.01% | 1667 |
|
|
2020
Q3 | – | Sell |
-23,400
| Closed | -$251K | – | 1645 |
|
|
2020
Q2 | $251K | Buy |
+23,400
| New | +$251K | 0.01% | 1383 |
|